Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China · Delayed Price · Currency is CNY 8.27
-0.13 (-1.55%)
Sep 2, 2026, 3:00 PM CST
SHA:688098 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -27.98 | -20.5 | -44.74 | 31.52 | 61.1 | 110.2 |
Depreciation & Amortization | 82.15 | 75.16 | 68.64 | 63.45 | 57.07 | 43.74 |
Other Amortization | -3.69 | 0.27 | - | - | - | - |
Loss (Gain) From Sale of Assets | -0.11 | -0.26 | -0.04 | -0 | -0.14 | 0.6 |
Asset Writedown & Restructuring Costs | 0.41 | 0.04 | 28.46 | 0.4 | 0.24 | - |
Loss (Gain) From Sale of Investments | 3.85 | 0.6 | -2.67 | -5.79 | -3.31 | -12.08 |
Provision & Write-off of Bad Debts | 8.79 | 13.32 | 8.45 | 3.12 | 8.5 | 1.65 |
Other Operating Activities | 7.1 | -3.9 | -3.93 | -1.68 | -0.11 | -5.82 |
Change in Accounts Receivable | -48.85 | -34.22 | 5.03 | -52.18 | -78.96 | -27.68 |
Change in Inventory | -21.38 | 0.64 | 16.68 | 3.58 | -11.9 | -32.27 |
Change in Accounts Payable | 11.19 | 3.29 | 21.42 | -33.15 | -17.88 | 5.25 |
Change in Other Net Operating Assets | - | - | - | -6.81 | -6.14 | 5.07 |
Operating Cash Flow | 7.8 | 33.08 | 89.36 | 3.53 | 9.09 | 90.12 |
Operating Cash Flow Growth | -84.64% | -62.99% | 2434.71% | -61.21% | -89.92% | -19.34% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -37.28 | -45.23 | -84.91 | -129.63 | -93.12 | -188.16 |
Sale of Property, Plant & Equipment | 0.54 | 0.52 | - | - | 0.86 | 0.5 |
Investment in Securities | -17.4 | -8 | 78.94 | 141.45 | 119.3 | 49.4 |
Other Investing Activities | 2.98 | 3.55 | 2.29 | 10.05 | 8.98 | 11.06 |
Investing Cash Flow | -51.16 | -49.16 | -3.68 | 21.86 | 36.01 | -127.21 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | 14 | - | - | - |
Long-Term Debt Issued | - | - | 0.02 | - | - | - |
Total Debt Issued | 40 | - | 14.02 | - | - | - |
Short-Term Debt Repaid | - | -1.12 | - | - | - | - |
Long-Term Debt Repaid | - | -0.46 | -0.78 | -0.37 | -0.12 | -0.14 |
Total Debt Repaid | -1.24 | -1.58 | -0.78 | -0.37 | -0.12 | -0.14 |
Net Debt Issued (Repaid) | 38.76 | -1.58 | 13.25 | -0.37 | -0.12 | -0.14 |
Issuance of Common Stock | - | - | - | - | - | 8.14 |
Repurchase of Common Stock | - | -1.68 | -18.32 | - | - | - |
Common Dividends Paid | -0.41 | -0.27 | -14.35 | -32.77 | -36.81 | -40.81 |
Other Financing Activities | 16.05 | 0.02 | 0.07 | 0.05 | 0.24 | 0.51 |
Financing Cash Flow | 54.4 | -3.51 | -19.36 | -33.09 | -36.7 | -32.3 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | 0 | -0 |
Net Cash Flow | 11.04 | -19.59 | 66.33 | -7.71 | 8.4 | -69.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -29.48 | -12.16 | 4.45 | -126.11 | -84.04 | -98.04 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -10.59% | -4.22% | 1.47% | -41.83% | -25.57% | -27.35% |
Free Cash Flow Per Share | -0.08 | -0.03 | 0.01 | -0.32 | -0.21 | -0.24 |
Levered Free Cash Flow | -41.25 | 9.37 | 18.33 | -113.09 | -92.62 | -126.34 |
Unlevered Free Cash Flow | -41.15 | 9.73 | 18.36 | -113.08 | -92.62 | -126.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 18.96 | 12.23 | 15.06 | 30.93 | 24.25 | 28.43 |
Change in Working Capital | -62.71 | -31.66 | 35.19 | -87.5 | -114.26 | -48.17 |